Hologic, Inc. (HOLX)

NASDAQ: HOLX · Real-Time Price · USD
74.01
+0.06 (0.08%)
Oct 28, 2025, 4:00 PM EDT - Market closed
0.08%
Market Cap16.46B
Revenue (ttm)4.04B
Net Income (ttm)557.10M
Shares Out 222.42M
EPS (ttm)2.41
PE Ratio30.66
Forward PE16.81
Dividendn/a
Ex-Dividend Daten/a
Volume3,334,762
Open73.97
Previous Close73.95
Day's Range73.85 - 74.10
52-Week Range51.90 - 84.39
Beta0.63
AnalystsHold
Price Target79.00 (+6.74%)
Earnings DateNov 3, 2025

About HOLX

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginos... [Read more]

Sector Healthcare
IPO Date Jun 21, 1990
Employees 7,063
Stock Exchange NASDAQ
Ticker Symbol HOLX
Full Company Profile

Financial Performance

In 2024, Hologic's revenue was $4.03 billion, a decrease of -0.00% compared to the previous year's $4.03 billion. Earnings were $789.50 million, an increase of 73.14%.

Financial Statements

Analyst Summary

According to 15 analysts, the average rating for HOLX stock is "Hold." The 12-month stock price target is $79.0, which is an increase of 6.74% from the latest price.

Price Target
$79.0
(6.74% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Hologic Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Hologic, Inc. - HOLX

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Holog...

6 days ago - Business Wire

Blackstone, TPG to Buy Hologic for Up to $18.3 Billion

Under the terms of the deal, Blackstone and TPG agreed to acquire all outstanding shares of the women's-health company for $76 apiece in cash.

Other symbols: BXTPG
7 days ago - WSJ

Blackstone, TPG to acquire medical device maker Hologic in up to $18.3 billion deal

Blackstone and TPG have agreed to acquire medical diagnostics firm Hologic in an up to $18.3 billion deal, the company said on Tuesday.

Other symbols: BXTPG
7 days ago - Reuters

Hologic to be Acquired by Blackstone and TPG for up to $79 per Share

MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)---- $HOLX #aquisition--Hologic to be Acquired by Blackstone and TPG for up to $79 per Share.

7 days ago - Business Wire

Hologic Stock Rises as Report Says Blackstone and TPG in Advanced Takeover Talks

The maker of women's health products rejected a $16 billion offer from the parties in May.

Other symbols: BXTPG
8 days ago - Barrons

Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025.

26 days ago - Business Wire

Hologic Receives FDA Clearance and CE Mark for Automated Molecular Tests to Detect Common Causes of Infectious Gastroenteritis

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #Bacterial--Hologic, Inc. (Nasdaq: HOLX) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Panther Fus...

26 days ago - Business Wire

New Survey Results Underscore the Need to #BustTheMyth About Mammograms

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #BCAM--New Survey Results Underscore the Need to #BustTheMyth About Mammograms.

4 weeks ago - Business Wire

Volition Signs Co-Marketing and Services Agreement with Hologic

HENDERSON, Nev. , Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, today announces that it has signed an agreement with Holog...

Other symbols: VNRX
4 weeks ago - PRNewsWire

Minicarm.com Named Exclusive U.S. Distributor of Hologic's Fluoroscan® Insight FD Mini C-Arm

HAUPPAUGE, N.Y. , Sept. 29, 2025 /PRNewswire/ -- Minicarm.com, a leading provider of imaging solutions for orthopedic and surgical practices, is proud to announce that it has secured an allocation of ...

4 weeks ago - PRNewsWire

New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #AI--New Data on Hologic's AI-Powered Mammography Technology to Be Presented at EUSOBI.

4 weeks ago - Business Wire

Blackstone and TPG revive interest in buying Hologic, source says

Private equity firms Blackstone and TPG revived their interest in acquiring medical device maker Hologic , a person close to the transaction said on Wednesday.

Other symbols: BXTPG
5 weeks ago - Reuters

Hologic, Inc. (HOLX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Hologic, Inc. (NASDAQ:HOLX) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 10:45 AM EDT Company Participants Stephen MacMillan - Chairman, CEO & President Conference Call P...

7 weeks ago - Seeking Alpha

Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic to Webcast Presentation at the 23rd Annual Morgan Stanley Global Healthcare Conference.

7 weeks ago - Business Wire

Hologic, Inc. (HOLX) Q3 2025 Earnings Call Transcript

Hologic, Inc. (NASDAQ:HOLX) Q3 2025 Earnings Conference Call July 30, 2025 4:30 PM ET Company Participants Essex D. Mitchell - Chief Operating Officer Karleen M.

3 months ago - Seeking Alpha

Hologic raises annual profit forecast on diagnostic and surgical demand

Medical equipment maker Hologic on Wednesday raised its annual profit forecast, anticipating strong demand for its molecular diagnostic devices and surgical products.

3 months ago - Reuters

Hologic Announces Financial Results for Third Quarter of Fiscal 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic Announces Financial Results for Third Quarter of Fiscal 2025.

3 months ago - Business Wire

Hologic Q3 Preview: Tariff Pressure And Undervalued Stock Price, Initiate With Buy

I am initiating a Buy rating on Hologic, Inc. with a fair value of $81, as current risks are priced in. Hologic's strong diagnostic portfolio, recurring consumables revenue, and expanding assay menu s...

3 months ago - Seeking Alpha

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025.

4 months ago - Business Wire

Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation

ARLINGTON, Va.--(BUSINESS WIRE)--NEST, an initiative of MDIC, is pleased to welcome Hologic, a leading global medical device company, to its Governance Committee.

5 months ago - Business Wire

Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?

Private equity firms TPG and Blackstone BX recently bid to acquire Hologic Inc. HOLX, valuing the U.S. medical technology company at over $16 billion.

5 months ago - Benzinga

Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports

Medical equipment maker Hologic rejected a $16 billion non-binding offer from private equity firms TPG and Blackstone , the Financial Times reported on Tuesday, citing people familiar with the matter.

Other symbols: BXTPG
5 months ago - Reuters

Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #ASCO--Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test.

5 months ago - Business Wire

Hologic to Webcast Presentations at Upcoming Investor Conferences

MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #holx--Hologic to Webcast Presentations at Upcoming Investor Conferences.

6 months ago - Business Wire

Hologic: Soft Performance, But Cheap Enough

Hologic, Inc.'s appeal has increased due to reduced debt, serial buybacks, and modest valuations, despite recent negative organic growth and pricey acquisitions. The company has shown solid long-term ...

6 months ago - Seeking Alpha